June 24, 2005
Philip A. Beachy, HHMI/ The Johns Hopkins University School of Medicine
Brian Drucker, HHMI/ Oregon Health & Science University Cancer Institute
Daniel Haber, Massachusetts General Hospital
Susan Hellmann, Genentech, Inc.
Pearl Huang, GlaxoSmithKline
William Kaelin, Dana-Farber Cancer Institute
Robert Langer, Massachusetts Institute of Technology
Frank McCormick, USCF Comprehensive Cancer Center
Victoria Richon, Merck & Co., Inc.
Robert Weinberg, Whitehead Institute, MIT